Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated-dose Decapeptyl versus single-dose Decapeptyl in women with PCOS undergoing assisted reproduction
IRCT20180708040381N5Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2024
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of triptorelin in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Number of mature oocytes, Number of retrieved oocytes and 1 more. Started Jun 2024; status: completed.
02
Drugs
triptorelin
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20180708040381N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180708040381N5.